Trius Therapeutics Inc
Trius Therapeutics Inc (TSRX) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 149 transactions totaling $47.8M, demonstrating a bullish sentiment with $44.5M in net insider flow. The most recent transaction on Sep 11, 2013 involved a transaction of 2,455 shares valued at $0.
TSRX Insider Activity Summary
Who Is Buying TSRX Stock?
No significant insider buying has been recorded for TSRX in the recent period.
Who Is Selling TSRX Stock?
No significant insider selling has been recorded for TSRX in the recent period.
Is Trius Therapeutics Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TSRX is bullish with an Insider Alignment Score of 96/100 and a net flow of $44.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TSRX Frequently Asked Questions
Understanding TSRX Insider Activity
Insider trading at Trius Therapeutics Inc (TSRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading TSRX stock, having executed 149 transactions in the past 90 days. The most active insider is Nina S. Kjellson (Executive), who has made 3 transactions totaling $9.4M.
Related Tools
Track Trius Therapeutics Inc Insider Activity
Get notified when executives and directors at TSRX file new Form 4 transactions